Galapagos NV
GLPG
#4567
Rank
HK$17.08 B
Marketcap
HK$259.25
Share price
0.42%
Change (1 day)
37.38%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: HK$17.08 Billion

As of January 2026 Galapagos NV has a market cap of HK$17.08 Billion. This makes Galapagos NV the world's 4567th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$17.08 B0.88%
2025HK$16.93 B21.26%
2024HK$13.96 B-33.24%
2023HK$20.92 B-8.36%
2022HK$22.82 B-19.86%
2021HK$28.48 B-43.25%
2020HK$50.19 B-52.29%
2019HK$105.21 B167.69%
2018HK$39.30 B4.75%
2017HK$37.52 B62.38%
2016HK$23.10 B20.95%
2015HK$19.10 B331.6%
2014HK$4.42 B-8.92%
2013HK$4.86 B10.95%
2012HK$4.38 B58.12%
2011HK$2.77 B-16.32%
2010HK$3.31 B67.51%
2009HK$1.97 B148.88%
2008HK$0.79 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Galapagos NV was reported to be:

HK$17.08 Billion
by Nasdaq info icon info icon
HK$17.08 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
HK$2.284 T 13,273.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$4.013 T 23,392.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$891.63 B 5,119.13%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$3.042 T 17,706.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
HK$0.94 B-94.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.686 T 9,773.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$290.45 B 1,600.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$786.33 B 4,502.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$2.108 T 12,241.42%๐Ÿ‡บ๐Ÿ‡ธ USA